Your browser doesn't support javascript.
loading
The danger of relying on the APTT and PT in patients on DOAC therapy, a potential patient safety issue.
Adcock, D M; Gosselin, R C.
Afiliación
  • Adcock DM; Colorado Coagulation, Laboratory Corporation of America® Holdings, Englewood, CO, USA.
  • Gosselin RC; University of California, Davis, Davis, CA, USA.
Int J Lab Hematol ; 39 Suppl 1: 37-40, 2017 May.
Article en En | MEDLINE | ID: mdl-28447415
Prolongation of the activated partial thromboplastin time (APTT) and prothrombin time/international normalized ratio (PT/INR) correlates poorly with plasma concentrations of direct oral anticoagulant agents (DOACS) including direct thrombin and direct Xa inhibitors. It has been repeatedly demonstrated that patients can have normal APTT and PT/INR with a therapeutic plasma concentration of a DOAC. Clinicians can no longer rely on a normal APTT and PT to determine that an anticoagulated patient is safe to undergo an invasive procedure. Laboratory scientists need to play a key and active role in educating clinicians about the limitations of the APTT and PT in patients on DOAC prophylaxis or therapy.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tiempo de Protrombina / Monitoreo de Drogas / Relación Normalizada Internacional / Anticoagulantes Límite: Humans Idioma: En Revista: Int J Lab Hematol Asunto de la revista: HEMATOLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tiempo de Protrombina / Monitoreo de Drogas / Relación Normalizada Internacional / Anticoagulantes Límite: Humans Idioma: En Revista: Int J Lab Hematol Asunto de la revista: HEMATOLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido